image
BioCryst Pharmaceuticals, Inc. BCRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.03
-5.64 %
$ 1.46 B
Market Cap
-11.92
P/E
BALANCE SHEET
517 M ASSETS
-6.01%
Growth Rates
1Year -6.01%
3Years 15.59%
5Years 28.62%
7Years 28.40%
10Years 26.60%
972 M LIABILITIES
15.14%
Growth Rates
1Year 15.14%
3Years 40.06%
5Years 58.37%
7Years 40.89%
10Years 34.55%
-456 M EQUITY
68.68%
Growth Rates
1Year 68.68%
3Years 23.65%
5Years 9.05%
7Years 3.06%
10Years -0.75%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition BioCryst Pharmaceuticals, Inc.
image
Current Assets 496 M
Cash & Short-Term Investments 391 M
Receivables 57 M
Other Current Assets 48.2 M
Non-Current Assets 21 M
Long-Term Investments 0
PP&E 21 M
Other Non-Current Assets 0
Current Liabilities 150 M
Accounts Payable 20.9 M
Short-Term Debt 2.65 M
Other Current Liabilities 126 M
Non-Current Liabilities 822 M
Long-Term Debt 822 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994
ASSETS
Cash & Cash Equivalents 110.6 304.8 504.4 272.1 114.2 26.7 50.3 22.1 28.9 54.5 21.2 20.9 16.4 13.6 41.1 22.3 31.2 4.4 29.2 8.8 11.9 13.8 18.9 8.5 8.6 12.3 3.8 3.6 6.1 2.7
Short Term Investments 278.3 119.5 3.2 28.2 22.1 77.7 64.1 32.5 22.7 18.2 16.9 14.7 25.3 40.3 27.8 39.2 19.5 33.0 21.1 14.3 8.1 10.6 13.1 16.2 14.5 0 0 0 0 0
Receivables 57.0 50.6 29.4 8.6 22.1 4.3 6.1 8.8 6.2 9.5 2.1 4.6 7.6 30.2 33.7 12.0 39.1 4.6 30.0 0 0 0 0 0 0 0 0 0 0 0
Inventory 28.7 27.5 15.8 7.0 1.6 1.6 (37.8) 0.5 1.6 0.7 (2.4) (0.4) 0.3 0.9 6.3 (13 494.7) (41 005.3) (8 328.3) (51 942.4) 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 21.3 14.1 13.3 7.7 6.0 3.9 4.9 3.1 4.4 6.4 2.0 1.8 3.3 2.3 2.1 1.5 1.9 3.8 0.8 0.7 0.7 0.5 0.4 1.1 1.5 10.6 15.9 24.5 5.6 8.4
Total Current Assets 496.0 516.5 566.1 323.8 164.3 114.4 125.4 67.0 66.0 89.3 42.1 42.0 63.6 97.7 111.0 75.0 91.7 45.8 81.1 23.9 20.7 24.9 32.4 25.8 24.6 22.9 19.7 28.1 11.7 11.1
PP&E 21.0 15.4 8.7 7.1 7.3 9.1 9.5 9.9 5.1 0.2 0.3 0.6 1.1 1.9 3.9 4.9 5.3 3.0 2.4 2.8 3.5 4.6 5.4 3.8 1.8 1.4 1.6 1.1 1.4 1.7
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.2 0.2 0.2 97.5 K 0.3 0.3 0.2 100 K 100 K 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 18.1 6.8 0 0 22.4 41.3 8.9 47.7 41.1 2.6 1.2 15.4 11.8 24.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 (33.5) 6.5 3.8 3.6 1.0 2.0 4.0 5.7 6.2 3.9 13.7 2.2 (0.8) 2.6 4.8 45.7 19.4 15.6 5.5 5.7 11.7 21.0 40.9 46.8 4.7 5.1 7.9 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 517.0 550.0 588.2 334.7 175.3 146.8 178.3 89.8 124.6 136.9 48.9 57.4 82.2 110.6 142.2 84.7 142.7 68.5 99.2 32.5 30.1 41.3 59.1 70.8 73.4 29.1 26.5 37.1 13.1 12.8
LIABILITIES
Accounts Payable 20.9 14.4 27.8 18.7 14.0 7.8 6.3 4.3 9.3 2.8 4.2 4.0 2.5 8.2 18.1 5.3 19.8 5.9 8.8 2.0 0.6 0.3 0.6 0.8 0.3 0.2 0.2 0.6 0.4 0.3
Short Term Debt 2.6 2.4 1.8 31.2 40.0 33.7 35.2 28.2 27.8 30.0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79 K 0 0 100 K 0.2 0.3 0.3
Other Current Liabilities 126.4 87.2 70.0 55.5 36.2 27.7 24.6 19.8 22.9 17.7 9.6 11.9 14.0 17.3 16.7 9.3 3.7 2.1 1.7 0.9 0.7 0.6 1.4 (38.1) 1.4 0.9 0.6 0.6 0.4 0.2
Total Current Liabilities 150.0 105.5 103.7 105.7 92.3 69.5 74.8 54.4 64.5 57.7 15.3 17.2 12.3 27.8 37.3 17.1 28.1 10.7 11.4 2.8 1.3 0.9 2.0 4.1 1.7 1.1 0.9 1.4 1.1 0.8
Long Term Debt 822.5 739.1 591.4 248.3 44.7 28.1 19.5 25.5 2.4 0 30.0 30.0 30.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 K 0.3 0.6
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 (4.7) 0 (7.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 54 K 0.2 0.2 0.3 0 0 4.7 4.0 0 0.2 0.2 0 0 0 0.3 0.3 0.3 0.3 5.2 0.3 0.3 0.3 0.2 0.4 0.2
Total Liabilities 972.5 844.6 695.1 354.0 137.0 97.6 94.5 88.3 76.8 61.2 50.0 57.9 67.4 43.9 55.9 38.3 77.8 47.3 40.8 3.1 1.6 1.2 2.3 9.3 2.0 1.4 1.2 1.7 1.8 1.6
EQUITY
Common Stock 2.1 1.9 1.8 1.8 1.5 1.1 1.0 0.7 0.7 0.7 0.6 0.5 0.5 0.4 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0 0 0 0 0
Retained Earnings (1 681.2) (1 454.6) (1 207.5) (1 023.4) (840.6) (732.0) (631.8) (566.1) (510.9) (467.9) (422.7) (392.6) (353.5) (295.5) (262.7) (249.3) (224.5) (195.5) (151.9) (125.8) (104.7) (92.0) (75.0) (70.0) (58.5) (53.2) (48.4) (37.8) (30.1) (21.5)
Other Accumulative Comprehensive Income/Loss 1.3 26 K 0.2 3 K 39 K (0.3) (0.2) 12 K (0.2) (0.1) 4 K 27 K 40 K 0.1 25.8 K 0.1 0.4 32.5 K 0 0 0 0 0 0 0 0 0 0 0 0
Total Equity (455.5) (1 454.6) (1 207.5) (1 023.4) (840.6) (732.0) (631.8) (566.1) (510.9) (467.9) (422.7) (392.6) 14.8 66.6 86.3 46.4 64.9 21.2 58.4 29.3 28.4 40.1 56.8 61.5 71.4 27.7 25.3 35.4 11.3 11.2
Total Liabilities and Equity 517.0 (610.0) (512.4) (669.5) (703.6) (634.4) (537.4) (477.8) (434.1) (406.7) (372.7) (334.7) 82.2 110.6 142.2 84.7 142.7 68.5 99.2 32.5 30.1 41.3 59.1 70.8 73.4 29.1 26.5 37.1 13.1 12.8
SHARES OUTSTANDING
Common Shares Outstanding 192.2 185.9 179.1 167.3 115.6 103.2 84.5 73.7 72.9 66.8 55.2 49.5 45.1 44.6 38.9 38.1 32.8 29.1 25.7 21.2 17.7 17.6 17.6 17.5 15.4 14.1 13.8 11.2 9.0 6.8